132 related articles for article (PubMed ID: 38513167)
1. Peritoneal Tumor DNA as a Prognostic Biomarker in Gastric Cancer: A Systematic Review and Meta-Analysis.
Allan Z; Witts S; Wong DJ; Lee MM; Tie J; Tebbutt NC; Clemons NJ; Liu DS
JCO Precis Oncol; 2024 Mar; 8():e2300546. PubMed ID: 38513167
[TBL] [Abstract][Full Text] [Related]
2. Tumor DNA in Peritoneal Lavage as a Novel Biomarker for Predicting Peritoneal Recurrence in Patients With Gastric Cancer.
Yukawa N; Yamada T; Aoyama T; Woo T; Ueda K; Mastuda A; Hara K; Kazama K; Tamagawa H; Sato T; Oshima T; Suzuki A; Aburatani H; Ishikawa S; Saito A; Masuda M; Yoshida H; Rino Y
Anticancer Res; 2023 May; 43(5):2069-2076. PubMed ID: 37097663
[TBL] [Abstract][Full Text] [Related]
3. The prognostic impact of peritoneal tumour DNA in gastrointestinal and gynaecological malignancies: a systematic review.
Allan Z; Witts S; Tie J; Tebbutt N; Clemons NJ; Liu DS
Br J Cancer; 2023 Nov; 129(11):1717-1726. PubMed ID: 37700064
[TBL] [Abstract][Full Text] [Related]
4. Peritoneal Lavage Tumor DNA as a Novel Biomarker for Predicting Peritoneal Recurrence in Pancreatic Ductal Adenocarcinoma.
Suenaga M; Fujii T; Yamada S; Hayashi M; Shinjo K; Takami H; Niwa Y; Sonohara F; Shimizu D; Kanda M; Kobayashi D; Tanaka C; Nakayama G; Koike M; Fujiwara M; Kondo Y; Kodera Y
Ann Surg Oncol; 2021 Apr; 28(4):2277-2286. PubMed ID: 32875467
[TBL] [Abstract][Full Text] [Related]
5. Prospective study to validate the clinical utility of DNA diagnosis of peritoneal fluid cytology test in gastric cancer.
Harada H; Soeno T; Nishizawa N; Washio M; Sakuraya M; Ushiku H; Niihara M; Hosoda K; Kumamoto Y; Naitoh T; Sangai T; Hiki N; Yamashita K
Cancer Sci; 2021 Apr; 112(4):1644-1654. PubMed ID: 33576114
[TBL] [Abstract][Full Text] [Related]
6. [Application of laparoscopic exploration combined with abdominal exfoliative cytology in the diagnosis and treatment of locally advanced gastric cancer].
Ding PA; Liu Y; Guo HH; Yang PG; Tian Y; Fan LQ; Tan BB; Li Y; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb; 23(2):170-176. PubMed ID: 32074798
[No Abstract] [Full Text] [Related]
7. Staging laparoscopy and peritoneal cytology in patients with early stage gastric adenocarcinoma.
Allen CJ; Blumenthaler AN; Das P; Minsky BD; Blum M; Roy-Chowdhuri S; Ajani JA; Ikoma N; Mansfield PF; Badgwell BD
World J Surg Oncol; 2020 Feb; 18(1):39. PubMed ID: 32066454
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of peritoneal lavage cytology in staging gastric cancer: systematic review and meta-analysis.
Jamel S; Markar SR; Malietzis G; Acharya A; Athanasiou T; Hanna GB
Gastric Cancer; 2018 Jan; 21(1):10-18. PubMed ID: 28779261
[TBL] [Abstract][Full Text] [Related]
9. Peritoneal Cell-Free Tumor DNA is a Biomarker of Locoregional and Peritoneal Recurrence in Resected Pancreatic Ductal Adenocarcinomas.
Leick KM; Tomanek-Chalkley A; Coleman KL; Chan CHF
Ann Surg Oncol; 2023 Oct; 30(11):6652-6660. PubMed ID: 37303025
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of intraperitoneal CD44 mRNA levels of magnetically separated CD45-negative EpCAM-positive cells for peritoneal recurrence and prognosis in stage II and III gastric cancer patients.
Horikawa M; Iinuma H; Inoue T; Ogawa E; Fukushima R
Oncol Rep; 2011 May; 25(5):1413-20. PubMed ID: 21331451
[TBL] [Abstract][Full Text] [Related]
11. Free intraperitoneal tumor cells and outcome in gastric cancer patients: a systematic review and meta-analysis.
Pecqueux M; Fritzmann J; Adamu M; Thorlund K; Kahlert C; Reißfelder C; Weitz J; Rahbari NN
Oncotarget; 2015 Nov; 6(34):35564-78. PubMed ID: 26384352
[TBL] [Abstract][Full Text] [Related]
12. Peritoneal cytology does not increase the prognostic information provided by TNM in gastric cancer.
de Manzoni G; Verlato G; Di Leo A; Tomezzoli A; Pedrazzani C; Pasini F; Piubello Q; Cordiano C
World J Surg; 2006 Apr; 30(4):579-84. PubMed ID: 16568221
[TBL] [Abstract][Full Text] [Related]
13. Aberrant gene methylation is a biomarker for the detection of cancer cells in peritoneal wash samples from advanced gastric cancer patients.
Hiraki M; Kitajima Y; Koga Y; Tanaka T; Nakamura J; Hashiguchi K; Noshiro H; Miyazaki K
Ann Surg Oncol; 2011 Oct; 18(10):3013-9. PubMed ID: 21409489
[TBL] [Abstract][Full Text] [Related]
14. Exosomal miRNAs from Peritoneum Lavage Fluid as Potential Prognostic Biomarkers of Peritoneal Metastasis in Gastric Cancer.
Tokuhisa M; Ichikawa Y; Kosaka N; Ochiya T; Yashiro M; Hirakawa K; Kosaka T; Makino H; Akiyama H; Kunisaki C; Endo I
PLoS One; 2015; 10(7):e0130472. PubMed ID: 26208314
[TBL] [Abstract][Full Text] [Related]
15. The critical role of peritoneal cytology in the staging of gastric cancer: an evidence-based review.
De Andrade JP; Mezhir JJ
J Surg Oncol; 2014 Sep; 110(3):291-7. PubMed ID: 24850538
[TBL] [Abstract][Full Text] [Related]
16. Rt-PCR increases detection of submicroscopic peritoneal metastases in gastric cancer and has prognostic significance.
Wong J; Kelly KJ; Mittra A; Gonen M; Allen P; Fong Y; Coit D
J Gastrointest Surg; 2012 May; 16(5):889-96; discussion 896. PubMed ID: 22362071
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for peritoneal dissemination of gastric cancer.
Yeldan E; Oguz S; Usta U; Ilhan E; Senlikci A
Minerva Chir; 2015 Apr; 70(2):91-6. PubMed ID: 25815699
[TBL] [Abstract][Full Text] [Related]
18. Observational Study of Peritoneal Washing Cytology-Positive Gastric Cancer without Gross Peritoneal Metastasis in Patients who Underwent Radical D2 Gastrectomy.
Shim HJ; Kim HJ; Lee SH; Bae WK; Hwang EC; Cho SH; Chung IJ; Bang HJ; Hwang JE
Sci Rep; 2020 Jun; 10(1):9549. PubMed ID: 32533084
[TBL] [Abstract][Full Text] [Related]
19. Detection of micrometastases in peritoneal washings of gastric cancer patients by the reverse transcriptase polymerase chain reaction.
Dalal KM; Woo Y; Kelly K; Galanis C; Gonen M; Fong Y; Coit DG
Gastric Cancer; 2008; 11(4):206-13. PubMed ID: 19132482
[TBL] [Abstract][Full Text] [Related]
20. Detection of minimal gastric cancer cells in peritoneal washings by focused microarray analysis with multiple markers: clinical implications.
Mori K; Suzuki T; Uozaki H; Nakanishi H; Ueda T; Matsuno Y; Kodera Y; Sakamoto H; Yamamoto N; Sasako M; Kaminishi M; Sasaki H
Ann Surg Oncol; 2007 May; 14(5):1694-702. PubMed ID: 17294072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
